The rationality for using prodrug approach in drug discovery programs for new xenobiotics: opportunities and challenges

Author： Srinivas Nuggehally  

Publisher： Springer Publishing Company

ISSN： 0378-7966

Source： European Journal of Drug Metabolism and Pharmacokinetics, Vol.36, Iss.2, 2011-06, pp. : 49-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prodrug Design to Improve Pharmacokinetic and Drug Delivery Properties: Challenges to the Discovery Scientists

By  

Current Medicinal Chemistry, Vol. 17, Iss. 32, 2010-11 ,pp. : 3874-3908

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin receptors: new opportunities in drug discovery

By Wikberg J.E.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 1, 2001-01 ,pp. : 61-76

Informa Healthcare

Access to resources Recommend Favorite

Inflammation in Atherosclerosis: New Opportunities for Drug Discovery

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 1, 2005-01 ,pp. : 33-40

Bentham Science Publishers

Access to resources Recommend Favorite

Current Prodrug Design for Drug Discovery

By  

Current Pharmaceutical Design, Vol. 15, Iss. 19, 2009-07 ,pp. : 2236-2250

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery

By  

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3073-3081

Bentham Science Publishers

Access to resources Recommend Favorite